Form 4: 10x Genomics Director Alan Mateo Acquires 40,000 Shares of Class A Common Stock

Director Alan Mateo of 10x Genomics, Inc. purchased 40,000 shares of Class A Common Stock at an average price of $11.1393 on February 21, 2025.

Summary

• On February 21, 2025, Alan Mateo, a director of 10x Genomics, Inc. (TXG), acquired 40,000 shares of Class A Common Stock.
• The purchase was made at a weighted average price of $11.1393 per share, with individual trades ranging from $11.04 to $11.2751.
• Following the transaction, Mateo directly owns 61,691 shares of 10x Genomics Class A Common Stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard insider transaction. The purchase itself is a positive signal, but it's a single transaction and doesn't provide definitive insight into the company's overall health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into a company's prospects, although they don't always predict future performance.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates